Quarter Period Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7257328

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
115,918,000,000 JPY
130,087,000,000 JPY
119,532,000,000 JPY
105,157,000,000 JPY
Cost of sales
59,667,000,000 JPY
70,551,000,000 JPY
67,904,000,000 JPY
56,581,000,000 JPY
Gross profit (loss)
56,250,000,000 JPY
59,535,000,000 JPY
51,628,000,000 JPY
48,576,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
2,318,000,000 JPY
2,381,000,000 JPY
Selling, general and administrative expenses
43,348,000,000 JPY
46,967,000,000 JPY
45,394,000,000 JPY
41,682,000,000 JPY
Operating profit (loss)
12,902,000,000 JPY
12,567,000,000 JPY
6,234,000,000 JPY
6,893,000,000 JPY
Non-operating income
Interest income
147,000,000 JPY
1,000,000 JPY
41,000,000 JPY
76,000,000 JPY
Dividend income
504,000,000 JPY
496,000,000 JPY
459,000,000 JPY
578,000,000 JPY
Share of profit of entities accounted for using equity method
38,000,000 JPY
JPY
Non-operating income
990,000,000 JPY
870,000,000 JPY
735,000,000 JPY
804,000,000 JPY
Non-operating expenses
Interest expenses
164,000,000 JPY
173,000,000 JPY
66,000,000 JPY
56,000,000 JPY
Share of loss of entities accounted for using equity method
JPY
12,000,000 JPY
Non-operating expenses
187,000,000 JPY
218,000,000 JPY
146,000,000 JPY
66,000,000 JPY
Ordinary profit (loss)
13,706,000,000 JPY
13,219,000,000 JPY
6,822,000,000 JPY
7,632,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
0 JPY
0 JPY
Extraordinary income
0 JPY
103,000,000 JPY
1,404,000,000 JPY
48,537,000,000 JPY
Extraordinary losses
Loss on disaster
JPY
27,000,000 JPY
Extraordinary losses
486,000,000 JPY
551,000,000 JPY
987,000,000 JPY
938,000,000 JPY
Profit (loss) before income taxes
13,219,000,000 JPY
12,770,000,000 JPY
7,239,000,000 JPY
55,231,000,000 JPY
Income taxes - current
4,167,000,000 JPY
3,807,000,000 JPY
1,897,000,000 JPY
2,046,000,000 JPY
Income taxes - deferred
-329,000,000 JPY
-123,000,000 JPY
-133,000,000 JPY
40,000,000 JPY
Income taxes
3,837,000,000 JPY
3,684,000,000 JPY
1,764,000,000 JPY
2,086,000,000 JPY
Profit (loss)
9,382,000,000 JPY
9,382,000,000 JPY
9,382,000,000 JPY
9,086,000,000 JPY
9,382,000,000 JPY
53,144,000,000 JPY
5,475,000,000 JPY
53,144,000,000 JPY
53,144,000,000 JPY
53,144,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
9,086,000,000 JPY
9,086,000,000 JPY
9,086,000,000 JPY
5,475,000,000 JPY
5,475,000,000 JPY
5,475,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-381,000,000 JPY
201,000,000 JPY
Deferred gains or losses on hedges
13,000,000 JPY
JPY
Foreign currency translation adjustment
JPY
-340,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-145,000,000 JPY
2,736,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
0 JPY
30,000,000 JPY
Other comprehensive income
-513,000,000 JPY
2,627,000,000 JPY
Comprehensive income
8,572,000,000 JPY
8,102,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
8,572,000,000 JPY
8,102,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.